Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
7.43
+0.13 (1.78%)
At close: Aug 14, 2026, 4:00 PM EDT
7.44
0.00 (0.07%)
After-hours: Aug 14, 2026, 7:34 PM EDT

Precision BioSciences Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, Precision BioSciences stock has a consensus rating of "Strong Buy" and an average price target of $29.4. The average 1-year stock price forecast is 295.69% higher than the current stock price, while the lowest is $18 (+142.26%) and the highest is $60 (+707.54%).

Price Target: $29.4 (+295.69%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$18$29.4$20$60
Change+142.26%+295.69%+169.18%+707.54%

Analyst Ratings

The average analyst rating for Precision BioSciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy444555
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total444555

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$60
BuyReiterates$60+707.54%Aug 12, 2026
Oppenheimer
Oppenheimer
Buy
Initiates
$20
BuyInitiates$20+169.18%Jun 9, 2026
Guggenheim
Guggenheim
Buy
Maintains
$19
BuyMaintains$19+155.72%May 28, 2026
JonesTrading
JonesTrading
Buy
Initiates
$30
BuyInitiates$30+303.77%Apr 16, 2026

Financial Forecast

Revenue This Year
12.16M
from 34.26M
Decreased by -64.51%
Revenue Next Year
9.58M
from 12.16M
Decreased by -21.25%
EPS This Year
-3.73
from -3.63
EPS Next Year
-1.88
from -3.73
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
115.53M25.10M48.73M68.70M34.26M12.16M
Revenue Growth
375.72%-78.28%94.15%40.98%-50.12%-64.51%
Gross Profit
115.53M25.10M48.73M68.70M34.26M12.16M
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Income
-39.38M-62.31M-43.74M-26.16M-52.15M-77.18M
Net Income
-30.60M-111.64M-61.32M7.17M-45.72M-98.98M
EPS
-----3.63-3.73
Free Cash Flow
-12.85M17.64M-50.41M-2.34M-21.97M-58.80M
No. Analysts
-----4
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High15.8M
Avg12.2M
Low10.8M

Revenue Growth

Revenue Growth202620272028
High
-53.8%
Avg
-64.5%
Low
-68.5%

EPS Forecast

EPS202620272028
High-3.03
Avg-3.73
Low-4.43

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-